Homocysteine Combined with Apolipoprotein B as Serum Biomarkers for Predicting Carotid Atherosclerosis in the Oldest-Old

References

• Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA. Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol. 2015;12(9):508–530. doi:10.1038/nrcardio.2015.82
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi:10.1093/eurheartj/ehw106
   PubMed Web of Science ®Google Scholar
• Bonati LH, Jansen O, de Borst GJ, Brown MM. Management of atherosclerotic extracranial carotid artery stenosis. Lancet Neurol. 2022;21(3):273–283. doi:10.1016/S1474-4422(21)00359-8
   PubMed Web of Science ®Google Scholar
• Howard D, Gaziano L, Rothwell PM; Oxford Vascular Study. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 2021;20(3):193–202. doi:10.1016/S1474-4422(20)30484-1
   PubMed Web of Science ®Google Scholar
• Brunner G, Virani SS, Sun W, et al. Associations between carotid artery plaque burden, plaque characteristics, and cardiovascular events: the ARIC carotid magnetic resonance imaging study. JAMA Cardiol. 2021;6(1):79–86. doi:10.1001/jamacardio.2020.5573
   PubMed Web of Science ®Google Scholar
• Bos D, Arshi B, van den Bouwhuijsen Q, et al. Atherosclerotic carotid plaque composition and incident stroke and coronary events. J Am Coll Cardiol. 2021;77(11):1426–1435. doi:10.1016/j.jacc.2021.01.038
   PubMed Web of Science ®Google Scholar
• Song P, Fang Z, Wang H, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8(5):e721–e729. doi:10.1016/S2214-109X(20)30117-0
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–467. doi:10.1161/CIRCULATIONAHA.106.628875
   PubMed Web of Science ®Google Scholar
• Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1):56.
   PubMed Web of Science ®Google Scholar
• Kamtchum-Tatuene J, Saba L, Heldner MR, et al. Interleukin-6 predicts carotid plaque severity, vulnerability, and progression. Circ Res. 2022;131(2):e22–e33. doi:10.1161/CIRCRESAHA.122.320877
   PubMed Web of Science ®Google Scholar
• Siniscalchi A, Murphy S, Gray C, De Sarro G, Gallelli L. Biomarkers in unstable carotid plaque: physiopathology and prediction. Cardiovasc Hematol Agents Med Chem. 2022;20(1):13–19. doi:10.2174/1871525719666210901131509
   PubMedGoogle Scholar
• Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis. 2010;213(1):21–29. doi:10.1016/j.atherosclerosis.2010.05.013
   PubMed Web of Science ®Google Scholar
• Ammirati E, Moroni F, Norata GD, Magnoni M, Camici PG. Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis. Mediators Inflamm. 2015;2015:718329. doi:10.1155/2015/718329
   PubMed Web of Science ®Google Scholar
• Loftus I, Thompson M. Plaque biology: interesting science or pharmacological treasure trove. Eur J Vasc Endovasc Surg. 2008;36(5):507–516. doi:10.1016/j.ejvs.2008.06.002
   PubMed Web of Science ®Google Scholar
• Avgerinos ED, Kadoglou NP, Moulakakis KG, Giannakopoulos TG, Liapis CD. Current role of biomarkers in carotid disease: a systematic review. Int J Stroke. 2011;6(4):337–345. doi:10.1111/j.1747-4949.2011.00623.x
   PubMed Web of Science ®Google Scholar
• Martinez E, Martorell J, Riambau V. Review of serum biomarkers in carotid atherosclerosis. J Vasc Surg. 2020;71(1):329–341. doi:10.1016/j.jvs.2019.04.488
   PubMed Web of Science ®Google Scholar
• He Y, Zhao Y, Yao Y, et al. Cohort profile: the China Hainan Centenarian Cohort Study (CHCCS). Int J Epidemiol. 2018;47(3):694–695h. doi:10.1093/ije/dyy017
   PubMed Web of Science ®Google Scholar
• Chen C, Liu GG, Sun Y, et al. Association between household fuel use and sleep quality in the oldest-old: evidence from a propensity-score matched case-control study in Hainan, China. Environ Res. 2020;191:110229. doi:10.1016/j.envres.2020.110229
   PubMed Web of Science ®Google Scholar
• Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290–296. doi:10.1159/000343145
   PubMed Web of Science ®Google Scholar
• Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;151(5):478–487. doi:10.1093/oxfordjournals.aje.a010233
   PubMed Web of Science ®Google Scholar
• Rimmele DL, Borof K, Jensen M, et al. Association between carotid atherosclerosis and atrial fibrillation, cardiac, and renal function. Eur J Vasc Endovasc Surg. 2022;63(4):641–647. doi:10.1016/j.ejvs.2022.01.010
   PubMed Web of Science ®Google Scholar
• Boulos NM, Gardin JM, Malik S, Postley J, Wong ND. Carotid plaque characterization, stenosis, and intima-media thickness according to age and gender in a large registry cohort. Am J Cardiol. 2016;117(7):1185–1191. doi:10.1016/j.amjcard.2015.12.062
   PubMed Web of Science ®Google Scholar
• Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–1009. doi:10.2215/CJN.06870909
   PubMed Web of Science ®Google Scholar
• Bytyçi I, Shenouda R, Wester P, Henein MY. Carotid atherosclerosis in predicting coronary artery disease: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol. 2021;41(4):e224–e237. doi:10.1161/ATVBAHA.120.315747
   PubMed Web of Science ®Google Scholar
• Gupta A, Baradaran H, Schweitzer AD, et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke. 2013;44(11):3071–3077. doi:10.1161/STROKEAHA.113.002551
   PubMed Web of Science ®Google Scholar
• McCully KS. Homocysteine metabolism, atherosclerosis, and diseases of aging. Compr Physiol. 2015;6(1):471–505.
   PubMed Web of Science ®Google Scholar
• Adachi H, Hirai Y, Fujiura Y, Matsuoka H, Satoh A, Imaizumi T. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke. 2002;33(9):2177–2181. doi:10.1161/01.STR.0000026861.18199.89
   PubMed Web of Science ®Google Scholar
• McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation. 1999;99(18):2383–2388. doi:10.1161/01.CIR.99.18.2383
   PubMed Web of Science ®Google Scholar
• Kim SJ, Song P, Park JH, et al. Biomarkers of asymptomatic carotid stenosis in patients undergoing coronary artery bypass grafting. Stroke. 2011;42(3):734–739. doi:10.1161/STROKEAHA.110.595546
   PubMed Web of Science ®Google Scholar
• Kim JM, Park KY, Shin DW, Park MS, Kwon OS. Relation of serum homocysteine levels to cerebral artery calcification and atherosclerosis. Atherosclerosis. 2016;254:200–204. doi:10.1016/j.atherosclerosis.2016.10.023
   PubMed Web of Science ®Google Scholar
• Alsulaimani S, Gardener H, Elkind MS, Cheung K, Sacco RL, Rundek T. Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke. 2013;44(2):457–461. doi:10.1161/STROKEAHA.112.676155
   PubMed Web of Science ®Google Scholar
• Zhang T, Jiang Y, Zhang S, et al. The association between homocysteine and ischemic stroke subtypes in Chinese: a meta-analysis. Medicine (Baltimore). 2020;99(12):e19467. doi:10.1097/MD.0000000000019467
   PubMed Web of Science ®Google Scholar
• Pushpakumar S, Kundu S, Sen U. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Curr Med Chem. 2014;21(32):3662–3672. doi:10.2174/0929867321666140706142335
   PubMed Web of Science ®Google Scholar
• Liu C, Sun X, Lin H, et al. Association between hyperhomocysteinemia and metabolic syndrome with early carotid artery atherosclerosis: a cross-sectional study in middle-aged Chinese population. Nutrition. 2018;53:115–119. doi:10.1016/j.nut.2018.02.014
   PubMed Web of Science ®Google Scholar
• Li Y, Wang L, Zhang W, Fang Y, Niu X. No association between elevated homocysteine levels and carotid atherosclerosis in a rural population in China. Stroke Vasc Neurol. 2016;1(4):154–160. doi:10.1136/svn-2016-000037
   PubMedGoogle Scholar
• Tsai MY, Arnett DK, Eckfeldt JH, Williams RR, Ellison RC. Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study. Atherosclerosis. 2000;151(2):519–524. doi:10.1016/S0021-9150(99)00409-8
   PubMed Web of Science ®Google Scholar
• Spence JD, Azarpazhooh MR, Larsson SC, Bogiatzi C, Hankey GJ. Stroke prevention in older adults: recent advances. Stroke. 2020;51(12):3770–3777. doi:10.1161/STROKEAHA.120.031707
   PubMed Web of Science ®Google Scholar
• Koklesova L, Mazurakova A, Samec M, et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA J. 2021;12(4):477–505. doi:10.1007/s13167-021-00263-0
   PubMed Web of Science ®Google Scholar
• Juonala M, Viikari JS, Kähönen M, et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J Am Coll Cardiol. 2008;52(4):293–299. doi:10.1016/j.jacc.2008.03.054
   PubMed Web of Science ®Google Scholar
• Raitakari OT, Mäkinen VP, McQueen MJ, et al. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. Atherosclerosis. 2013;226(1):245–251. doi:10.1016/j.atherosclerosis.2012.10.049
   PubMed Web of Science ®Google Scholar
• Morita SY. Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis. Biol Pharm Bull. 2016;39(1):1–24. doi:10.1248/bpb.b15-00716
   PubMed Web of Science ®Google Scholar
• Sniderman AD, Williams K, Contois JH, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337–345. doi:10.1161/CIRCOUTCOMES.110.959247
   PubMed Web of Science ®Google Scholar
• Steffen BT, Guan W, Remaley AT, et al. Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of multi-ethnic study of atherosclerosis participants. J Clin Lipidol. 2017;11(5):1181–1191.e1. doi:10.1016/j.jacl.2017.07.001
   PubMed Web of Science ®Google Scholar
• Razavi AC, Bazzano LA, He J, et al. Discordantly normal ApoB relative to elevated LDL-C in persons with metabolic disorders: a marker of atherogenic heterogeneity. Am J Prev Cardiol. 2021;7:100190. doi:10.1016/j.ajpc.2021.100190
   PubMedGoogle Scholar
• Tzoulaki I, Castagné R, Boulangé CL, et al. Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. Eur Heart J. 2019;40(34):2883–2896. doi:10.1093/eurheartj/ehz235
   PubMed Web of Science ®Google Scholar
• Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004;35(7):1619–1624. doi:10.1161/01.STR.0000130857.19423.ad
   PubMed Web of Science ®Google Scholar
• Duivenvoorden R, Mani V, Woodward M, et al. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. JACC Cardiovasc Imaging. 2013;6(10):1087–1094. doi:10.1016/j.jcmg.2013.03.009
   PubMed Web of Science ®Google Scholar
• Rudd JH, Myers KS, Bansilal S, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2(2):107–115. doi:10.1161/CIRCIMAGING.108.811752
   PubMed Web of Science ®Google Scholar
• Wang A, Huang X, Liu X, et al. No association between high-sensitivity C-reactive protein and carotid intima-media progression: the APAC study. J Stroke Cerebrovasc Dis. 2017;26(2):252–259. doi:10.1016/j.jstrokecerebrovasdis.2016.09.013
   PubMed Web of Science ®Google Scholar
• Shah T, Casas JP, Cooper JA, et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol. 2009;38(1):217–231. doi:10.1093/ije/dyn217
   PubMed Web of Science ®Google Scholar
• Li D, Qiao H, Yang X, et al. Co-existing hypertension and hyperhomocysteinemia increases the risk of carotid vulnerable plaque and subsequent vascular event: an MR vessel wall imaging study. Front Cardiovasc Med. 2022;9:858066. doi:10.3389/fcvm.2022.858066
   PubMed Web of Science ®Google Scholar